To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FLAD1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
488 supporting clones for gene FLAD1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_025207.4   .a 1 to 2239 1 to 2239 exact RefSeq, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 2239/2239
(100 %)
0 diff
(100 %id)
DA821303 pericardium .a 43 to 617 2 to 577   tiling clone, capped   576/576
(100 %)
2 diff
(99.7 %id)
BE010782 breast_normal .a 57 to 288 21 to 253       233/253
(92 %)
6 diff
(97.7 %id)
DA904293   .a 59 to 624 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA715889   .a 60 to 603 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA594085 lung .a 62 to 574 2 to 514   capped   513/514
(99 %)
1 diff
(99.9 %id)
DB206617 trachea .a 62 to 643 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DB244822 uterus, tumor tissue .a 66 to 634 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA630889 Kidney .a 68 to 644 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
AW246098 lung, small cell carcinoma .a 78 to 645 9 to 576       568/576
(98 %)
6 diff
(99.0 %id)
AF520568 skin .a 80 to 2239 1 to 2160 exact tiling clone, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 2160/2160
(100 %)
0 diff
(100 %id)
BG742333 skin .a 80 to 901 1 to 828       828/866
(95 %)
19 diff
(97.9 %id)
BI757689 brain .a 92 to 774 1 to 689       689/880
(78 %)
10 diff
(98.9 %id)
TI_57219395   .a 92 to 774 35 to 723       689/914
(75 %)
10 diff
(99.0 %id)
BJ991918 hepatoblastoma .a 93 to 643 1 to 551       551/551
(100 %)
1 diff
(99.9 %id)
DA209404 brain .a 95 to 659 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BG472211 eye, retinoblastoma .a 105 to 903 1 to 824       688/824
(83 %)
46 diff
(94.5 %id)
BE257525 eye, retinoblastoma .a 125 to 746 1 to 620       620/649
(95 %)
11 diff
(98.4 %id)
BE618413 eye, retinoblastoma .a 138 to 833 1 to 688       688/705
(97 %)
13 diff
(98.2 %id)
CV799580 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 153 to 692 1 to 531       531/565
(93 %)
17 diff
(97.0 %id)
DQ458779 skin .a 402 to 2165 1 to 1764 exact     1764/1764
(100 %)
0 diff
(100 %id)
BE314012 brain, neuroblastoma .a 474 to 635 1 to 162       162/162
(100 %)
0 diff
(100 %id)
BE312409 brain, neuroblastoma .a 475 to 635 1 to 162       162/162
(100 %)
1 diff
(99.4 %id)
BE259545 brain, neuroblastoma .a 476 to 635 1 to 160       160/160
(100 %)
0 diff
(100 %id)
NM_201398.2   .b 1 to 1795 1 to 1795 exact RefSeq, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1795/1795
(100 %)
0 diff
(100 %id)
BG744367 blood, natural killer cells, cell line .b 48 to 211 1 to 164   tiling clone,   164/164
(100 %)
1 diff
(99.4 %id)
BC032323 Brain, fetal, whole pooled .b 66 to 1795 1 to 1730   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1730/1730
(100 %)
0 diff
(100 %id)
AK025979   .b 73 to 1795 1 to 1723   available from FLJ, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1723/1723
(100 %)
2 diff
(99.9 %id)
CR596936 Neuroblastoma Cot 25-normalized .b 73 to 1777 1 to 1705       1705/1705
(100 %)
0 diff
(100 %id)
CR602509 Neuroblastoma Cot 50-normalized .b 73 to 1746 1 to 1674       1674/1674
(100 %)
0 diff
(100 %id)
AL523900 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 73 to 890 1 to 796   fully sequenced,   796/796
(100 %)
2 diff
(99.8 %id)
BX365900 Neuroblastoma Cot 50-normalized .b 73 to 892 1 to 819   fully sequenced,   819/819
(100 %)
5 diff
(99.4 %id)
CR625722 Neuroblastoma Cot 10-normalized .b 79 to 1779 1 to 1701       1701/1701
(100 %)
0 diff
(100 %id)
CR606793 B cells (Ramos cell line) Cot 25-normalized .b 80 to 1759 1 to 1680       1680/1680
(100 %)
0 diff
(100 %id)
CR617327 Neuroblastoma Cot 25-normalized .b 80 to 1735 1 to 1656       1656/1656
(100 %)
0 diff
(100 %id)
CR623743 B cells (Ramos cell line) Cot 25-normalized .b 80 to 1760 1 to 1681       1681/1681
(100 %)
0 diff
(100 %id)
BX402145 Neuroblastoma Cot 25-normalized .b 80 to 941 1 to 858   fully sequenced,   858/858
(100 %)
1 diff
(99.9 %id)
BX363694   .b 80 to 891 1 to 809   fully sequenced,   809/809
(100 %)
1 diff
(99.9 %id)
BX401785   .b 80 to 891 1 to 809   fully sequenced,   809/809
(100 %)
1 diff
(99.9 %id)
BI520523 brain, medulla .b 80 to 929 1 to 857   fully sequenced,   857/857
(100 %)
14 diff
(98.4 %id)
TI_43963689   .b 80 to 913 70 to 910   fully sequenced,   841/910
(92 %)
20 diff
(97.9 %id)
BC021096 Brain, neuroblastoma .b 83 to 1795 1 to 1713   available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1713/1713
(100 %)
0 diff
(100 %id)
TI_151793086   .b 86 to 695 113 to 722     Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 610/722
(84 %)
6 diff
(99.2 %id)
CR591714 B cells (Ramos cell line) Cot 25-normalized .b 102 to 1760 1 to 1659       1659/1659
(100 %)
0 diff
(100 %id)
CR599772 Neuroblastoma Cot 10-normalized .b 102 to 1777 1 to 1676       1676/1676
(100 %)
0 diff
(100 %id)
BX394225 Neuroblastoma Cot 25-normalized .b 102 to 976 1 to 870   fully sequenced,   870/870
(100 %)
8 diff
(99.1 %id)
BX383803   .b 102 to 1130 1 to 1016       1019/1016
(100 %)
23 diff
(97.8 %id)
BX363745   .b 102 to 899 1 to 801   fully sequenced,   801/801
(100 %)
7 diff
(99.2 %id)
AL561607 B cells from Burkitt lymphoma .b 102 to 904 1 to 791   fully sequenced,   791/791
(100 %)
2 diff
(99.8 %id)
AF481877 Liver .b 249 to 1721 1 to 1473       1473/1473
(100 %)
0 diff
(100 %id)
Z45642 brain, total brain .b 406 to 713 1 to 308       308/308
(100 %)
0 diff
(100 %id)
U79241 brain .b 406 to 1795 1 to 1390   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1390/1390
(100 %)
0 diff
(100 %id)
T77100 whole brain .b 444 to 827 1 to 383     Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 383/383
(100 %)
5 diff
(98.7 %id)
TI_1948134966   .b 716 to 1723 1134 to 124       1011/1302
(77 %)
38 diff
(97.1 %id)
TI_1948134432   .b 717 to 1723 1150 to 125       1026/1348
(76 %)
41 diff
(97.0 %id)
TI_1948134433   .b 719 to 1723 1123 to 126       998/1336
(74 %)
25 diff
(98.2 %id)
BC020253 Skin, melanotic melanoma, high MDR. .b 722 to 1795 1 to 1074   available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1074/1074
(100 %)
0 diff
(100 %id)
TI_1948133352   .b 736 to 1723 1107 to 124       984/1349
(72 %)
42 diff
(96.9 %id)
TI_1948133888   .b 742 to 1723 1114 to 122       993/1204
(82 %)
33 diff
(97.3 %id)
TI_1948133887   .b 746 to 1723 1080 to 124       957/1339
(71 %)
41 diff
(97.0 %id)
TI_1948133351   .b 808 to 1723 1041 to 124       918/1318
(69 %)
17 diff
(98.8 %id)
TI_1948134434   .b 815 to 1723 1035 to 124       912/1198
(76 %)
18 diff
(98.5 %id)
TI_1948134968   .b 815 to 1723 1039 to 125       915/1208
(75 %)
13 diff
(99.0 %id)
TI_1948134967   .b 816 to 1723 1023 to 121       903/1366
(66 %)
25 diff
(98.2 %id)
AL520871 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 831 to 1779 948 to 1       948/948
(100 %)
5 diff
(99.5 %id)
TI_1948133353   .b 838 to 1723 1022 to 122       901/1225
(73 %)
27 diff
(97.8 %id)
TI_1948133886   .b 838 to 1723 1031 to 126       906/1368
(66 %)
27 diff
(98.1 %id)
AL523585.
matches multiple genes
brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 839 to 1771 926 to 1     also hits gene GGT7 926/1053
(87 %)
18 diff
(98.3 %id)
AL562282 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 860 to 1777 909 to 1   fully sequenced,   909/909
(100 %)
14 diff
(98.5 %id)
BX363693   .b 861 to 1759 897 to 1   fully sequenced,   897/897
(100 %)
2 diff
(99.8 %id)
BX401784   .b 861 to 1760 900 to 1   fully sequenced,   900/900
(100 %)
2 diff
(99.8 %id)
BX363744   .b 869 to 1759 886 to 1   fully sequenced,   886/886
(100 %)
26 diff
(97.1 %id)
BX365899 Neuroblastoma Cot 50-normalized .b 874 to 1746 875 to 1   fully sequenced,   875/875
(100 %)
24 diff
(97.3 %id)
AL582769 B cells from Burkitt lymphoma .b 874 to 1760 879 to 1   fully sequenced,   879/879
(100 %)
3 diff
(99.7 %id)
BI090147 cervix .b 879 to 1685 1 to 807       805/807
(99 %)
17 diff
(97.9 %id)
BG744934 blood, natural killer cells, cell line .b 887 to 1745 854 to 8       847/855
(99 %)
17 diff
(98.1 %id)
BX344780 Neuroblastoma Cot 10-normalized .b 895 to 1734 851 to 12       840/851
(98 %)
1 diff
(99.9 %id)
TI_43963690   .b 904 to 1748 864 to 2   fully sequenced,   863/864
(99 %)
28 diff
(96.8 %id)
BI520599 brain, medulla .b 905 to 1748 863 to 2   fully sequenced,   862/863
(99 %)
28 diff
(96.8 %id)
BX402144 Neuroblastoma Cot 25-normalized .b 911 to 1735 825 to 1   fully sequenced,   825/825
(100 %)
3 diff
(99.7 %id)
BX394224 Neuroblastoma Cot 25-normalized .b 946 to 1741 803 to 1   fully sequenced,   803/803
(100 %)
24 diff
(97.1 %id)
AI140356 heart .b 1041 to 1795 756 to 2       755/756
(99 %)
13 diff
(98.3 %id)
BQ773253 Chondrosarcoma Cell line .b 1109 to 1795 705 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 687/687
(100 %)
4 diff
(99.5 %id)
BX352386   .b 1130 to 1794 667 to 1       667/721
(92 %)
34 diff
(95.3 %id)
AW079510 colon, moderately differentiated adenocarcinoma .b 1158 to 1795 639 to 2       638/639
(99 %)
20 diff
(96.9 %id)
BE782759 eye, retinoblastoma .b 1184 to 1793 1 to 609       609/904
(67 %)
8 diff
(99.2 %id)
AI636333 adenocarcinoma, Pancreas .b 1210 to 1791 585 to 2       584/786
(74 %)
7 diff
(99.2 %id)
BM853987 stomach .b 1217 to 1795 1 to 579   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 579/579
(100 %)
5 diff
(99.2 %id)
BQ301059 bladder_tumor .b 1219 to 1651 1 to 441       444/441
(100 %)
22 diff
(95.1 %id)
AI889757 adenocarcinoma, Pancreas .b 1221 to 1795 576 to 1       576/717
(80 %)
7 diff
(99.1 %id)
AA608951   .b 1245 to 1795 552 to 4       549/552
(99 %)
2 diff
(99.7 %id)
AI571385 anaplastic oligodendroglioma, brain .b 1248 to 1795 559 to 12   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 548/551
(99 %)
10 diff
(98.2 %id)
BX455159 brain, fetal brain .b 1261 to 1790 530 to 1       530/570
(92 %)
18 diff
(96.9 %id)
AI263167 pooled .b 1261 to 1795 536 to 4       533/536
(99 %)
5 diff
(99.1 %id)
AA609382   .b 1281 to 1795 521 to 8       514/521
(98 %)
0 diff
(100 %id)
AI281982 carcinoid, lung .b 1297 to 1795 505 to 7       499/506
(98 %)
0 diff
(100 %id)
AA983407 pooled germ cell tumors .b 1300 to 1795 496 to 1       496/499
(99 %)
9 diff
(98.2 %id)
AA812662   .b 1307 to 1795 492 to 4       489/492
(99 %)
0 diff
(100 %id)
AI078557 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1308 to 1794 487 to 1       487/487
(100 %)
0 diff
(100 %id)
AA552637 colon, tumor .b 1323 to 1794 472 to 1       472/472
(100 %)
2 diff
(99.6 %id)
AA641431 epithelium (cell line), Prostate .b 1323 to 1732 408 to 1       408/408
(100 %)
6 diff
(98.6 %id)
AA927209 pooled .b 1323 to 1701 380 to 2       379/380
(99 %)
10 diff
(97.4 %id)
AA947037 Kidney, kidney tumor .b 1323 to 1795 470 to 1       470/470
(100 %)
8 diff
(98.3 %id)
AA810585 germinal center B cell .b 1329 to 1795 476 to 11   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 466/466
(100 %)
14 diff
(97.0 %id)
AA622269 Prostate, prostate tumor .b 1336 to 1712 1 to 377     Submitted on the opposite strand 377/377
(100 %)
2 diff
(99.5 %id)
AI970066 Prostate .b 1339 to 1795 457 to 1       457/457
(100 %)
3 diff
(99.4 %id)
DB511533 testis .b 1340 to 1795 1 to 452     Submitted on the opposite strand 452/452
(100 %)
24 diff
(94.7 %id)
AA527497 colon .b 1344 to 1795 452 to 1       452/452
(100 %)
4 diff
(99.2 %id)
AW139608   .b 1351 to 1795 462 to 18   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 445/445
(100 %)
1 diff
(99.8 %id)
AA134076 colon, tumor .b 1354 to 1777 425 to 1       425/425
(100 %)
3 diff
(99.3 %id)
R80963 placenta .b 1363 to 1777 416 to 1       416/422
(98 %)
5 diff
(98.9 %id)
AA640012 normal prostate, Prostate .b 1365 to 1795 431 to 1       431/431
(100 %)
0 diff
(100 %id)
AI810477 Prostate .b 1365 to 1789 426 to 2       425/426
(99 %)
0 diff
(100 %id)
DB507380 testis .b 1370 to 1795 1 to 427     Submitted on the opposite strand 427/427
(100 %)
2 diff
(99.6 %id)
CD367791 Alveolar Macrophage, lung .b 1378 to 1795 436 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 418/418
(100 %)
1 diff
(99.8 %id)
AA714121 synovial sarcoma .b 1390 to 1794 405 to 1       405/406
(99 %)
4 diff
(99.1 %id)
AI860450 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 1403 to 1795 394 to 3       392/397
(98 %)
1 diff
(99.8 %id)
BQ026130 placenta .b 1405 to 1795 408 to 18   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 391/391
(100 %)
0 diff
(100 %id)
AW517730 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 1406 to 1716 311 to 1       311/340
(91 %)
16 diff
(95.3 %id)
R38171 whole brain .b 1409 to 1795 407 to 11   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 397/397
(100 %)
19 diff
(95.3 %id)
AA580875 bulk germ cell seminoma .b 1418 to 1795 381 to 5       377/381
(98 %)
0 diff
(100 %id)
TI_151750986   .b 1420 to 1794 518 to 143   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 376/1067
(35 %)
3 diff
(99.8 %id)
BP386809 pancreatic islet .b 1421 to 1794 1 to 374     Submitted on the opposite strand 374/380
(98 %)
1 diff
(99.8 %id)
AI350951 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1442 to 1795 352 to 1       354/435
(81 %)
14 diff
(96.8 %id)
AI215434 pooled .b 1454 to 1795 345 to 4       342/345
(99 %)
2 diff
(99.5 %id)
BF739946 Kidney .b 1486 to 1716 231 to 1       231/231
(100 %)
6 diff
(97.5 %id)
F32344 pectoral muscle (after mastectomy) .b 1489 to 1774 1 to 286       286/286
(100 %)
5 diff
(98.3 %id)
Z41315 brain, total brain .b 1493 to 1795 303 to 1       303/303
(100 %)
0 diff
(100 %id)
BI222931 cervical carcinoma cell line, cervix .b 1496 to 1795 1 to 300   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 300/300
(100 %)
0 diff
(100 %id)
BI223618 cervical carcinoma cell line, cervix .b 1496 to 1795 1 to 299       299/315
(94 %)
2 diff
(99.4 %id)
F37222 pectoral muscle (after mastectomy) .b 1498 to 1633 1 to 136       136/136
(100 %)
3 diff
(97.8 %id)
H24072.
matches multiple genes
whole brain .b 1502 to 1795 309 to 16   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base), also hits gene NR3C1 294/294
(100 %)
3 diff
(99.0 %id)
AW451627   .b 1513 to 1795 300 to 18   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 283/287
(98 %)
3 diff
(99.0 %id)
AI347340 colon, colon tumor, RER+ .b 1526 to 1795 279 to 10       270/279
(96 %)
0 diff
(100 %id)
FN143797 breast carcinoma .b 1533 to 1628 1 to 95       95/101
(94 %)
4 diff
(96.1 %id)
AW593854 pooled germ cell tumors .b 1543 to 1795 253 to 1       253/253
(100 %)
0 diff
(100 %id)
BE502278 pooled germ cell tumors .b 1543 to 1795 265 to 13   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 253/253
(100 %)
0 diff
(100 %id)
BU753783 placenta .b 1551 to 1795 262 to 18   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 245/245
(100 %)
2 diff
(99.2 %id)
BE676996 follicular carcinoma, thyroid .b 1558 to 1795 259 to 22   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 238/243
(97 %)
1 diff
(99.6 %id)
AI564522 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 1565 to 1795 233 to 3       231/233
(99 %)
0 diff
(100 %id)
DW416054 Liver .b 1567 to 1793 17 to 243   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 227/243
(93 %)
6 diff
(97.6 %id)
BP283594 bone marrow .c 1 to 579 1 to 581   tiling clone,   581/581
(100 %)
4 diff
(99.4 %id)
DC371856   .c 106 to 656 1 to 551       551/551
(100 %)
0 diff
(100 %id)
NM_001184891.1   .c 107 to 2016 1 to 1910 exact RefSeq, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1910/1910
(100 %)
0 diff
(100 %id)
DC385324 rectum .c 134 to 703 1 to 570       570/570
(100 %)
0 diff
(100 %id)
DC298962 adrenal gland .c 136 to 709 1 to 574       574/574
(100 %)
1 diff
(99.9 %id)
DC392798 breast, tumor tissue .c 138 to 692 1 to 555       555/555
(100 %)
2 diff
(99.7 %id)
DC312631 alzheimer cortex .c 139 to 696 1 to 558       558/558
(100 %)
0 diff
(100 %id)
DC358565 lung .c 139 to 683 1 to 545       545/545
(100 %)
0 diff
(100 %id)
DB470581 hippocampus .c 145 to 611 1 to 466       466/466
(100 %)
1 diff
(99.8 %id)
DB483663 hippocampus .c 145 to 596 1 to 452       452/453
(99 %)
2 diff
(99.6 %id)
DC302872 cerebellum .c 146 to 714 1 to 569       569/569
(100 %)
0 diff
(100 %id)
DC306338 cerebellum .c 146 to 706 1 to 561       561/561
(100 %)
0 diff
(100 %id)
BM829079 Ascites, stomach .c 146 to 303 1 to 158       158/158
(100 %)
0 diff
(100 %id)
DC325718 caudate nucleus .c 147 to 641 1 to 495       495/495
(100 %)
0 diff
(100 %id)
BP203126 coronary artery .c 147 to 713 1 to 567       567/568
(99 %)
3 diff
(99.5 %id)
DC386810   .c 147 to 707 1 to 561       561/561
(100 %)
1 diff
(99.9 %id)
BI919061 brain .c 154 to 827 30 to 712       683/712
(95 %)
29 diff
(96.0 %id)
TI_57241869   .c 154 to 827 30 to 712       683/712
(95 %)
29 diff
(96.0 %id)
AW162935 brain, frontal lobe .c 155 to 386 1 to 232       232/232
(100 %)
0 diff
(100 %id)
BM918179 blood, natural killer cells, cell line .c 155 to 1044 18 to 910       893/1078
(82 %)
40 diff
(96.3 %id)
BM920524 pooled lung and spleen .c 155 to 1115 18 to 993       976/1110
(87 %)
33 diff
(97.1 %id)
BX441246 brain, fetal brain .c 156 to 735 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
BI766825 pooled lung and spleen .c 156 to 1065 1 to 911       911/1019
(89 %)
25 diff
(97.6 %id)
TI_57180723   .c 156 to 1065 66 to 976       911/1084
(84 %)
31 diff
(97.2 %id)
BQ883926 brain, neuroblastoma, cell line .c 158 to 1046 1 to 910       910/948
(95 %)
23 diff
(97.6 %id)
BX483080   .c 160 to 848 1 to 689       689/689
(100 %)
6 diff
(99.2 %id)
DA146017 amygdala .c 161 to 627 2 to 468   capped   467/470
(99 %)
2 diff
(99.6 %id)
DB442526 testis .c 163 to 597 1 to 434       434/434
(100 %)
4 diff
(99.1 %id)
DB011199 colon, tumor tissue .c 163 to 727 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB189930 lung, tumor tissue .c 163 to 679 2 to 518   capped   517/517
(100 %)
1 diff
(99.9 %id)
DB446390 testis .c 164 to 608 1 to 444       444/444
(100 %)
8 diff
(98.2 %id)
BP327490 prostata .c 164 to 744 1 to 584       584/584
(100 %)
3 diff
(99.5 %id)
BG118018 adenocarcinoma, cell line, Liver .c 165 to 925 1 to 750       750/788
(95 %)
14 diff
(98.3 %id)
CX870730 embryonic stem .c 165 to 830 1 to 665       665/665
(100 %)
1 diff
(99.9 %id)
DB034755 testis .c 165 to 730 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DB052596 testis .c 165 to 736 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA001323   .c 166 to 674 2 to 510   capped   509/509
(100 %)
0 diff
(100 %id)
DA058771 cerebellum .c 166 to 699 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DA465962   .c 166 to 699 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
BG540380 lung .c 166 to 836 1 to 670       670/670
(100 %)
5 diff
(99.3 %id)
BG822959 adenocarcinoma cell line, colon .c 166 to 317 1 to 153       153/153
(100 %)
1 diff
(99.4 %id)
DA605551   .c 166 to 793 2 to 629   capped   628/628
(100 %)
0 diff
(100 %id)
CB157271 Liver .c 166 to 590 1 to 425       425/425
(100 %)
3 diff
(99.3 %id)
DA669237 esophagus .c 166 to 641 2 to 477   capped   476/476
(100 %)
1 diff
(99.8 %id)
CT004046 T-Lymphocytes .c 166 to 830 1 to 671       671/671
(100 %)
7 diff
(99.0 %id)
DA968545 stomach .c 166 to 727 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA984752 synovial membrane tissue from rheumatioidarthritis .c 166 to 732 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA609224   .c 167 to 733 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
BM853330 myeloma .c 167 to 629 1 to 462       462/462
(100 %)
1 diff
(99.8 %id)
DB027032 testis .c 167 to 581 2 to 416   capped   415/415
(100 %)
1 diff
(99.8 %id)
DB108709 thymus .c 167 to 740 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
DB193824 ovary, tumor tissue .c 167 to 727 2 to 562   capped   561/561
(100 %)
3 diff
(99.5 %id)
DA255511 caudate nucleus .c 168 to 728 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA371130 thalamus .c 168 to 736 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA560132 heart .c 168 to 484 2 to 318   capped   317/317
(100 %)
0 diff
(100 %id)
BI752453 brain .c 168 to 1022 1 to 857       857/859
(99 %)
25 diff
(97.1 %id)
TI_57219132   .c 168 to 1022 35 to 891       857/893
(95 %)
31 diff
(96.6 %id)
DA727736   .c 168 to 699 2 to 532   capped   531/531
(100 %)
2 diff
(99.7 %id)
DA979382 synovial membrane tissue from rheumatioidarthritis .c 168 to 744 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA429898 colon .c 169 to 740 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA686889   .c 169 to 699 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
DA874770 Prostate .c 169 to 739 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA896677 skeletal muscle .c 169 to 737 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA897823 skeletal muscle .c 169 to 736 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB010953 colon, tumor tissue .c 169 to 721 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DB153665 thymus .c 169 to 736 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA835324 placenta .c 171 to 699 2 to 530   capped   529/529
(100 %)
4 diff
(99.3 %id)
BI521295 pooled pancreas and spleen .c 172 to 995 1 to 826       826/835
(98 %)
7 diff
(99.2 %id)
BI916712 brain .c 172 to 799 1 to 628       628/628
(100 %)
2 diff
(99.7 %id)
BQ071521 brain, neuroblastoma, cell line .c 172 to 1023 1 to 860       860/1072
(80 %)
19 diff
(98.3 %id)
BU187641 eye, retinoblastoma .c 172 to 1013 23 to 871       849/872
(97 %)
32 diff
(96.4 %id)
CD517031 White Matter .c 172 to 921 29 to 785       757/911
(83 %)
19 diff
(98.0 %id)
TI_57240209   .c 172 to 799 30 to 657       628/657
(95 %)
8 diff
(98.8 %id)
CR998772 T-Lymphocytes .c 172 to 976 1 to 805       805/806
(99 %)
3 diff
(99.7 %id)
DN995551 breast cancer, Mammary gland (cancer tissue) .c 172 to 762 1 to 591       591/591
(100 %)
3 diff
(99.5 %id)
AK308243 breast, tumor tissue .c 173 to 1167 1 to 996       996/996
(100 %)
4 diff
(99.6 %id)
BP254061 Kidney .c 173 to 749 1 to 582       582/586
(99 %)
13 diff
(97.8 %id)
DA980695 synovial membrane tissue from rheumatioidarthritis .c 173 to 699 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
DB054555 testis .c 173 to 724 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA013675 adrenal gland .c 174 to 729 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA054352 cerebellum .c 174 to 733 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA372821 thalamus .c 174 to 711 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA432265 colon .c 174 to 699 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
DA566693 heart .c 174 to 742 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BG250047 adenocarcinoma, cell line, Liver .c 174 to 851 1 to 685       685/981
(69 %)
32 diff
(96.8 %id)
DA608299   .c 174 to 732 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA610265   .c 174 to 715 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA614679   .c 174 to 699 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
DA624220 Kidney .c 174 to 726 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA695423   .c 174 to 727 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA759251   .c 174 to 634 2 to 462   capped   461/461
(100 %)
0 diff
(100 %id)
DA835249 placenta .c 174 to 699 2 to 527   capped   526/526
(100 %)
3 diff
(99.5 %id)
DA848129 placenta .c 174 to 415 2 to 243   capped   242/242
(100 %)
1 diff
(99.6 %id)
DB189658 lung, tumor tissue .c 174 to 699 2 to 527   capped   526/526
(100 %)
3 diff
(99.5 %id)
DB192547 ovary, tumor tissue .c 174 to 739 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BQ223759 embryonal carcinoma, cell line, testis .c 175 to 903 1 to 739       739/934
(79 %)
22 diff
(97.7 %id)
DA566322 heart .c 176 to 736 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
CB115431 Liver .c 176 to 696 1 to 521       521/521
(100 %)
1 diff
(99.9 %id)
BM818700 stomach .c 176 to 696 1 to 522       522/522
(100 %)
2 diff
(99.7 %id)
BP356208   .c 176 to 752 1 to 582       582/582
(100 %)
6 diff
(99.0 %id)
DA003974   .c 177 to 751 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA088753 cerebellum .c 177 to 741 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
CN301116 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 177 to 774 1 to 599       599/599
(100 %)
3 diff
(99.5 %id)
DA425443 colon .c 177 to 699 2 to 524   capped   523/523
(100 %)
0 diff
(100 %id)
BG831789 epithelioid carcinoma cell line, Pancreas .c 177 to 317 1 to 141       141/141
(100 %)
1 diff
(99.3 %id)
BI194173 epithelioid carcinoma cell line, Pancreas .c 177 to 896 1 to 728       728/907
(80 %)
39 diff
(95.8 %id)
BI766442 pooled lung and spleen .c 177 to 1066 1 to 892       892/892
(100 %)
11 diff
(98.8 %id)
TI_57177604   .c 177 to 1066 33 to 924       892/924
(96 %)
17 diff
(98.2 %id)
DA730305   .c 177 to 899 2 to 722   capped   721/721
(100 %)
5 diff
(99.4 %id)
DA968842 stomach .c 177 to 722 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA998057   .c 177 to 742 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
AA296432 umbilical vein .c 178 to 372 1 to 195       195/195
(100 %)
1 diff
(99.5 %id)
BC011378 Colon, adenocarcinoma .c 178 to 2016 1 to 1839   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1839/1839
(100 %)
1 diff
(100.0 %id)
CN301122 embryonic stem cells, DMSO-treated H9 cellline .c 178 to 572 1 to 396       396/396
(100 %)
1 diff
(99.8 %id)
BG328748 adenocarcinoma cell line, colon .c 178 to 317 1 to 140       140/140
(100 %)
2 diff
(98.6 %id)
BI334222 cervical carcinoma cell line, cervix .c 178 to 948 1 to 772       772/772
(100 %)
9 diff
(98.9 %id)
BM906819 ovary (pool of 3) .c 178 to 1187 12 to 1026       1015/1093
(92 %)
38 diff
(96.6 %id)
BQ068305 brain .c 178 to 901 16 to 758       743/1064
(69 %)
33 diff
(96.9 %id)
BQ955174 large cell carcinoma, lung .c 178 to 1124 5 to 954       950/955
(99 %)
14 diff
(98.6 %id)
CX761208 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 178 to 909 41 to 762     Submitted on the opposite strand 722/796
(90 %)
18 diff
(97.8 %id)
CF272234 Brain glioblastoma .c 178 to 1131 1 to 958       958/960
(99 %)
12 diff
(98.8 %id)
D31318   .c 179 to 496 1 to 320       320/320
(100 %)
7 diff
(97.9 %id)
CX761508 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 179 to 877 1 to 699     Submitted on the opposite strand 699/699
(100 %)
0 diff
(100 %id)
D31388   .c 180 to 471 1 to 291       291/291
(100 %)
2 diff
(99.4 %id)
BI088607 cervix .c 180 to 869 1 to 698       698/698
(100 %)
18 diff
(97.5 %id)
BU181903 eye, retinoblastoma .c 180 to 1042 1 to 872       872/896
(97 %)
13 diff
(98.6 %id)
DA606852   .c 180 to 699 2 to 522   capped   521/521
(100 %)
3 diff
(99.5 %id)
DA611728   .c 180 to 751 2 to 575   capped   574/574
(100 %)
4 diff
(99.4 %id)
TI_57236980   .c 180 to 903 33 to 753       721/753
(95 %)
9 diff
(98.9 %id)
BM819439 stomach .c 180 to 784 1 to 604       604/604
(100 %)
3 diff
(99.6 %id)
DA003506   .c 181 to 760 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
AA296434 umbilical vein .c 181 to 391 1 to 211       211/214
(98 %)
4 diff
(98.2 %id)
BQ918747 brain, neuroblastoma, cell line .c 181 to 1104 1 to 926       926/926
(100 %)
19 diff
(98.0 %id)
DA907166   .c 182 to 753 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA071335 cerebellum .c 183 to 758 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
BI758530 brain .c 183 to 1063 24 to 902       879/904
(97 %)
15 diff
(98.4 %id)
TI_57215552   .c 183 to 1063 24 to 902       879/904
(97 %)
15 diff
(98.4 %id)
TI_57181543   .c 184 to 1013 64 to 889       826/899
(91 %)
19 diff
(97.9 %id)
DA910953   .c 184 to 744 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
AL520872 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 185 to 1065 1 to 880       880/883
(99 %)
2 diff
(99.8 %id)
BX344781 Neuroblastoma Cot 10-normalized .c 185 to 1001 1 to 815       815/815
(100 %)
4 diff
(99.6 %id)
BF528674 anaplastic oligodendroglioma with 1p/19qloss, brain .c 185 to 917 1 to 735       735/1066
(68 %)
13 diff
(98.8 %id)
BI754823 brain .c 185 to 798 1 to 614       614/614
(100 %)
0 diff
(100 %id)
BU943923 adenocarcinoma, cell line, breast .c 185 to 1083 1 to 905       905/912
(99 %)
13 diff
(98.6 %id)
TI_57217324   .c 185 to 798 28 to 641       614/641
(95 %)
6 diff
(99.1 %id)
CN301120 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 186 to 803 8 to 625       618/625
(98 %)
6 diff
(99.1 %id)
BQ961192 large cell carcinoma, lung .c 186 to 1122 1 to 950       950/954
(99 %)
36 diff
(96.3 %id)
BU603071 mixed (pool of 40 RNAs) .c 186 to 1004 1 to 835       835/839
(99 %)
33 diff
(96.1 %id)
BI768881 pooled lung and spleen .c 187 to 1013 1 to 823       823/833
(98 %)
13 diff
(98.5 %id)
BM010892 brain, neuroblastoma, cell line .c 187 to 317 1 to 131       131/131
(100 %)
1 diff
(99.3 %id)
BM468343 melanotic melanoma, skin .c 187 to 877 10 to 700       691/970
(71 %)
20 diff
(98.0 %id)
BU187828 eye, retinoblastoma .c 187 to 719 9 to 539       531/782
(67 %)
28 diff
(96.5 %id)
BI196863 brain, neuroblastoma .c 188 to 317 1 to 129       129/129
(100 %)
3 diff
(97.7 %id)
TI_59379777   .c 188 to 1064 101 to 980       880/881
(99 %)
24 diff
(97.3 %id)
CN301113 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 190 to 869 7 to 686       680/686
(99 %)
7 diff
(99.0 %id)
BE791982 lung, small cell carcinoma .c 191 to 297 1 to 107       107/107
(100 %)
0 diff
(100 %id)
BM925036 pooled lung and spleen .c 191 to 1042 8 to 863       856/1062
(80 %)
18 diff
(98.4 %id)
CA455034   .c 192 to 989 1 to 804       804/920
(87 %)
14 diff
(98.5 %id)
CR984404 T-Lymphocytes .c 194 to 1096 1 to 906       906/910
(99 %)
4 diff
(99.6 %id)
CN301125 embryonic stem cells, DMSO-treated H9 cellline .c 195 to 769 1 to 575       575/575
(100 %)
0 diff
(100 %id)
CR991072 T-Lymphocytes .c 195 to 704 1 to 510       510/511
(99 %)
1 diff
(99.9 %id)
CT002983 T-Lymphocytes .c 195 to 949 1 to 755       755/755
(100 %)
0 diff
(100 %id)
BM479258 duodenal adenocarcinoma, cell line, small intestine .c 196 to 634 1 to 440       440/1255
(35 %)
11 diff
(99.2 %id)
AA300476 testis .c 197 to 451 1 to 255       255/255
(100 %)
6 diff
(97.7 %id)
BE796981 lung, small cell carcinoma .c 197 to 297 1 to 101       101/101
(100 %)
0 diff
(100 %id)
BI089478 cervix .c 197 to 1001 1 to 809       809/873
(92 %)
16 diff
(98.2 %id)
BI253471 cervical carcinoma cell line, cervix .c 197 to 919 1 to 728       728/728
(100 %)
8 diff
(99.0 %id)
BQ435343 leiomyosarcoma, uterus .c 197 to 1044 1 to 858       858/891
(96 %)
30 diff
(96.7 %id)
CX166397 human embryonic stem cells differentiated toan early endodermal cell type .c 198 to 990 1 to 793       793/793
(100 %)
0 diff
(100 %id)
CB110451 Liver .c 198 to 673 1 to 476       476/476
(100 %)
2 diff
(99.6 %id)
BE733323 choriocarcinoma, placenta .c 199 to 297 1 to 99       99/99
(100 %)
0 diff
(100 %id)
CN301119 embryonic stem cells, DMSO-treated H9 cellline .c 201 to 628 1 to 429       429/429
(100 %)
1 diff
(99.8 %id)
BE253623 eye, retinoblastoma .c 201 to 297 1 to 96       96/96
(100 %)
3 diff
(96.9 %id)
BU183573 melanotic melanoma, cell line, skin .c 201 to 1133 13 to 950       938/951
(98 %)
20 diff
(97.9 %id)
BQ677561 melanotic melanoma, cell line, skin .c 201 to 1043 18 to 866       849/964
(88 %)
24 diff
(97.6 %id)
BE266592 lung, small cell carcinoma .c 203 to 297 1 to 95       95/95
(100 %)
0 diff
(100 %id)
CN301123 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 204 to 821 1 to 619       619/619
(100 %)
2 diff
(99.7 %id)
BM453133 leiomyosarcoma, uterus .c 205 to 1109 1 to 911       911/1019
(89 %)
15 diff
(98.6 %id)
CN301114 embryonic stem cells, DMSO-treated H9 cellline .c 207 to 528 1 to 322       322/322
(100 %)
0 diff
(100 %id)
CV808137 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 207 to 1073 1 to 873       873/887
(98 %)
19 diff
(97.9 %id)
BE872679 adenocarcinoma, colon .c 208 to 943 10 to 758       749/1006
(74 %)
61 diff
(94.0 %id)
BE900809 choriocarcinoma, placenta .c 208 to 297 1 to 87       87/87
(100 %)
3 diff
(96.6 %id)
DN997744 breast cancer, Mammary gland (cancer tissue) .c 208 to 789 10 to 591       582/591
(98 %)
6 diff
(99.0 %id)
CN301117 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 211 to 587 1 to 377       377/377
(100 %)
0 diff
(100 %id)
CN301115 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 213 to 834 1 to 622       622/622
(100 %)
0 diff
(100 %id)
CN301124 embryonic stem cells, DMSO-treated H9 cellline .c 213 to 628 1 to 415       415/415
(100 %)
1 diff
(99.8 %id)
CN301118 embryonic stem cells, cell lines H1, H7, andH9 .c 217 to 836 1 to 619       619/619
(100 %)
1 diff
(99.9 %id)
CN301121 embryonic stem cells, cell lines H1, H7, andH9 .c 249 to 818 1 to 570       570/570
(100 %)
0 diff
(100 %id)
AA581051 bulk germ cell seminoma .c 292 to 386 1 to 95       95/95
(100 %)
1 diff
(99.0 %id)
AA346757 heart .c 315 to 490 1 to 175       175/175
(100 %)
3 diff
(98.3 %id)
BQ422561 large cell carcinoma, lung .c 332 to 1183 1 to 861       861/942
(91 %)
39 diff
(95.9 %id)
TI_57221610   .c 343 to 1247 32 to 936       905/975
(92 %)
30 diff
(97.0 %id)
BF527468 anaplastic oligodendroglioma with 1p/19qloss, brain .c 344 to 976 148 to 789       642/817
(78 %)
53 diff
(93.6 %id)
BI757062 brain .c 346 to 1247 1 to 902       902/941
(95 %)
24 diff
(97.5 %id)
TI_1948133348   .c 354 to 1181 133 to 964       832/1457
(57 %)
19 diff
(98.7 %id)
TI_1948133349   .c 354 to 1329 129 to 1112       984/1458
(67 %)
44 diff
(97.0 %id)
TI_1948133350   .c 354 to 1315 127 to 1100       972/1360
(71 %)
54 diff
(96.1 %id)
TI_1948133883   .c 354 to 1329 132 to 1103       972/1423
(68 %)
23 diff
(98.4 %id)
TI_1948133884   .c 354 to 1237 127 to 1000       874/1319
(66 %)
19 diff
(98.6 %id)
TI_1948133885   .c 354 to 1176 128 to 951       824/1376
(59 %)
15 diff
(99.0 %id)
TI_1948134429   .c 354 to 1327 133 to 1107       975/1458
(66 %)
32 diff
(97.9 %id)
TI_1948134430   .c 354 to 1284 128 to 1058       931/1401
(66 %)
27 diff
(98.1 %id)
TI_1948134431   .c 354 to 1325 126 to 1095       970/1334
(72 %)
45 diff
(96.7 %id)
TI_1948134963   .c 354 to 1181 131 to 954       824/1422
(57 %)
27 diff
(98.2 %id)
TI_1948134964   .c 354 to 1328 130 to 1097       968/1370
(70 %)
29 diff
(97.9 %id)
TI_1948134965   .c 354 to 1310 126 to 1085       958/1438
(66 %)
50 diff
(96.6 %id)
CV030555 mixed .c 355 to 1016 1 to 662       662/665
(99 %)
1 diff
(99.9 %id)
BY796370 eye .c 361 to 897 1 to 537       537/537
(100 %)
0 diff
(100 %id)
AA299467 uterus .c 378 to 582 1 to 204       204/204
(100 %)
3 diff
(98.6 %id)
BE901207 choriocarcinoma, placenta .c 407 to 1179 1 to 764   available from MGC,   764/784
(97 %)
18 diff
(97.8 %id)
BE901992 choriocarcinoma, placenta .c 407 to 1178 1 to 774       774/877
(88 %)
10 diff
(98.9 %id)
BP263147 small intestine .c 412 to 973 1 to 562       562/562
(100 %)
1 diff
(99.9 %id)
CB118632 Liver .c 429 to 979 1 to 551       551/551
(100 %)
0 diff
(100 %id)
BP300641   .c 464 to 1050 1 to 588       588/592
(99 %)
8 diff
(98.7 %id)
BE905524 epithelioid carcinoma, Pancreas .c 493 to 1184 1 to 690       690/954
(72 %)
56 diff
(94.2 %id)
BX282577 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 521 to 1004 1 to 484       484/484
(100 %)
0 diff
(100 %id)
BM453134 leiomyosarcoma, uterus .c 525 to 1433 1 to 916       916/992
(92 %)
16 diff
(98.4 %id)
BF525876 brain, glioblastoma with EGFR amplification .c 535 to 1321 1 to 775       775/802
(96 %)
28 diff
(96.6 %id)
AW387128 stomach .c 546 to 841 298 to 2       297/298
(99 %)
0 diff
(100 %id)
BG259540 embryonal carcinoma, cell line, testis .c 557 to 1298 1 to 733       733/983
(74 %)
26 diff
(97.4 %id)
H24180.
matches multiple genes
whole brain .c 576 to 970 1 to 395     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base), also hits gene NR3C1 395/397
(99 %)
6 diff
(98.5 %id)
TI_57168512   .c 593 to 1530 32 to 970       939/979
(95 %)
28 diff
(97.2 %id)
BI833098 pooled pancreas and spleen .c 598 to 1530 1 to 934       934/943
(99 %)
31 diff
(96.8 %id)
BG468674 adenocarcinoma cell line, colon .c 676 to 1273 1 to 610       610/765
(79 %)
21 diff
(97.3 %id)
AA301338 testis .c 683 to 987 1 to 307       307/307
(100 %)
6 diff
(98.1 %id)
BG674397 skin .c 689 to 1509 1 to 826       826/938
(88 %)
16 diff
(98.3 %id)
AW998062 breast_normal .c 716 to 825 1 to 108       108/116
(93 %)
4 diff
(96.6 %id)
EH316730   .c 726 to 789 1 to 65       65/65
(100 %)
3 diff
(95.4 %id)
FN084097 breast carcinoma .c 779 to 881 102 to 1     Submitted on the opposite strand 102/105
(97 %)
2 diff
(98.1 %id)
AI564766 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 781 to 1104 323 to 1       323/324
(99 %)
5 diff
(98.5 %id)
AI590113 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 784 to 1104 318 to 1       318/318
(100 %)
8 diff
(97.5 %id)
BE744569 adenocarcinoma cell line, ovary .c 786 to 1519 1 to 731       731/731
(100 %)
5 diff
(99.4 %id)
EC513494 Prostate .c 797 to 904 108 to 1       108/108
(100 %)
0 diff
(100 %id)
BG770506 melanotic melanoma, high MDR (cell line), skin .c 827 to 1547 1 to 722   available from MGC,   722/722
(100 %)
3 diff
(99.6 %id)
AW090247 brain, tumor, 5 pooled (see description) .c 870 to 1104 234 to 1       234/234
(100 %)
7 diff
(97.1 %id)
BM050137 epithelioid carcinoma cell line, Pancreas .c 891 to 1843 1 to 848       784/856
(91 %)
13 diff
(98.5 %id)
FN137884 breast carcinoma .c 998 to 1099 1 to 101       101/102
(99 %)
2 diff
(98.1 %id)
BF724527 eye, Iris .c 1029 to 1543 1 to 515       515/515
(100 %)
0 diff
(100 %id)
BE074590 breast .c 1031 to 1492 1 to 462       462/469
(98 %)
9 diff
(98.1 %id)
AA074544   .c 1055 to 1473 421 to 2     Submitted on the opposite strand 420/421
(99 %)
1 diff
(99.8 %id)
AI800820 pooled .c 1063 to 1183 127 to 7       121/127
(95 %)
0 diff
(100 %id)
AA317705 retina .c 1151 to 1407 13 to 269       257/276
(93 %)
11 diff
(96.1 %id)
AA352081   .c 1205 to 1320 1 to 116       116/116
(100 %)
0 diff
(100 %id)
F32483 pectoral muscle (after mastectomy) .c 1471 to 1655 1 to 185       185/185
(100 %)
1 diff
(99.5 %id)
AA716530 heart .c 1533 to 1671 139 to 1       139/139
(100 %)
0 diff
(100 %id)
BF346338 anaplastic oligodendroglioma with 1p/19qloss, brain .c 1824 to 2016 25 to 217   tiling clone, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 193/217
(88 %)
6 diff
(97.3 %id)
AA151884 colon, tumor .c 1836 to 2016 180 to 1       180/180
(100 %)
4 diff
(97.8 %id)
BQ022558 placenta .c 1854 to 2016 180 to 18   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 163/163
(100 %)
1 diff
(99.4 %id)
AW074929 bone marrow, stem cell 34+/38+ .c 1901 to 2014 20 to 134     Submitted on the opposite strand 115/135
(85 %)
6 diff
(95.6 %id)
DA049952   .d 1 to 553 7 to 559   tiling clone, capped   558/558
(100 %)
2 diff
(99.7 %id)
H16646 whole brain .d 591 to 992 1 to 412   tiling clone, Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 412/412
(100 %)
15 diff
(96.4 %id)
DB296221   .d 1538 to 2111 574 to 1   tiling clone,   574/574
(100 %)
0 diff
(100 %id)
H16503 whole brain .d 1744 to 2105 377 to 15   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 363/363
(100 %)
6 diff
(98.4 %id)
AK090542   .e 1 to 2656 1 to 2656 S318N tiling clone, available from FLJ,   2656/2656
(100 %)
1 diff
(100.0 %id)
AX746501   .e 1 to 2656 1 to 2656 S318N     2656/2656
(100 %)
1 diff
(100.0 %id)
DA019745   .e 2 to 504 2 to 504   capped   503/503
(100 %)
0 diff
(100 %id)
DB295507   .e 2130 to 2656 527 to 1       527/527
(100 %)
0 diff
(100 %id)
AL534385 brain, fetal brain .f 1 to 921 4 to 917   tiling clone, fully sequenced,   917/917
(100 %)
3 diff
(99.7 %id)
DA733946   .f 1 to 510 2 to 509   tiling clone, capped   508/508
(100 %)
13 diff
(97.5 %id)
AL565492 brain, fetal brain .f 891 to 1518 632 to 6   tiling clone, fully sequenced,   627/632
(99 %)
8 diff
(98.8 %id)
DB365946   .f 1301 to 1541 250 to 10   tiling clone,   241/250
(96 %)
1 diff
(99.6 %id)
CR622894 fetal liver .g 1 to 1726 1 to 1726 exact tiling clone,   1726/1726
(100 %)
0 diff
(100 %id)
BX406167 fetal liver, Liver .g 1 to 873 1 to 865   fully sequenced,   865/865
(100 %)
4 diff
(99.6 %id)
BX406166 fetal liver, Liver .g 843 to 1726 876 to 1   fully sequenced,   876/876
(100 %)
7 diff
(99.3 %id)
AI160475 heart .g 985 to 1775 800 to 2       799/802
(99 %)
22 diff
(97.3 %id)
AW957270   .g 999 to 1568 1 to 570       570/669
(85 %)
8 diff
(98.9 %id)
AA252087 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 1128 to 1360 1 to 233   fully sequenced,   233/233
(100 %)
1 diff
(99.6 %id)
BQ771540 Chondrosarcoma Grade II, Left Pelvis .g 1142 to 1775 652 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 634/634
(100 %)
0 diff
(100 %id)
BF528333 anaplastic oligodendroglioma with 1p/19qloss, brain .g 1149 to 1772 1 to 625       625/647
(96 %)
6 diff
(99.1 %id)
AA099740 uterus .g 1172 to 1387 1 to 217   fully sequenced,   217/217
(100 %)
1 diff
(99.6 %id)
AA251981 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 1330 to 1652 483 to 159   fully sequenced,   325/483
(67 %)
3 diff
(99.4 %id)
AA099741 uterus .g 1357 to 1757 403 to 1   fully sequenced,   403/403
(100 %)
6 diff
(98.6 %id)
BX331315 Neuroblastoma Cot 10-normalized .h 680 to 717 695 to 732   tiling clone,   732/732
(100 %)
6 diff
(99.2 %id)
BX350789 Neuroblastoma Cot 10-normalized .h 1112 to 1560 488 to 31   tiling clone,   458/561
(81 %)
0 diff
(100 %id)
BE065036 breast .h 1368 to 1620 1 to 251   tiling clone,   251/257
(97 %)
6 diff
(97.7 %id)
BE153802 head_neck .h 1371 to 1620 1 to 249   tiling clone,   249/255
(97 %)
8 diff
(96.9 %id)
BE064942 breast .h 1372 to 1620 1 to 248   tiling clone,   248/254
(97 %)
12 diff
(95.3 %id)
BI910264 leukocyte .i 1 to 719 2 to 721   tiling clone,   721/721
(100 %)
3 diff
(99.6 %id)
BP227754   .i 550 to 1131 1 to 582   tiling clone,   582/582
(100 %)
0 diff
(100 %id)
DA733379   .j 1 to 382 6 to 387   tiling clone, capped   386/386
(100 %)
6 diff
(98.5 %id)
DB365295   .j 1112 to 1656 540 to 1   tiling clone,   540/565
(95 %)
17 diff
(97.0 %id)
BM746856 Ascites, stomach .j 1130 to 1357 1 to 229   tiling clone,   229/229
(100 %)
1 diff
(99.6 %id)
BC014012 Placenta, choriocarcinoma .k 1 to 1211 1 to 1211 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1211/1211
(100 %)
0 diff
(100 %id)
BP280550   .l 1 to 609 1 to 609       609/609
(100 %)
5 diff
(99.2 %id)
DA728922   .l 1 to 825 2 to 827   tiling clone, capped   826/828
(99 %)
11 diff
(98.7 %id)
BE384125 melanotic melanoma, skin .l 36 to 333 1 to 296       296/296
(100 %)
2 diff
(99.4 %id)
BE872838 adenocarcinoma, colon .l 44 to 786 1 to 762       762/998
(76 %)
49 diff
(95.1 %id)
R15736 liver and spleen .l 505 to 778 1 to 274   tiling clone,   274/274
(100 %)
3 diff
(99.0 %id)
BM696968 eye, lens .l 961 to 1536 1 to 576   tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 576/576
(100 %)
0 diff
(100 %id)
H03735 placenta .l 1069 to 1424 1 to 361   fully sequenced,   361/361
(100 %)
8 diff
(97.8 %id)
R81071 placenta .l 1070 to 1421 1 to 360   fully sequenced,   360/360
(100 %)
9 diff
(97.5 %id)
H02841 placenta .l 1394 to 1789 395 to 1   fully sequenced,   395/395
(100 %)
3 diff
(99.3 %id)
R80964 placenta .l 1396 to 1772 384 to 3   fully sequenced,   382/384
(99 %)
9 diff
(97.7 %id)
BM667999 eye, lens .l 1475 to 1789 333 to 19   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 315/315
(100 %)
0 diff
(100 %id)
R16138 liver and spleen .l 1636 to 1789 158 to 6       153/158
(96 %)
0 diff
(100 %id)
BX380775 Placenta Cot 25-normalized .m 1 to 727 1 to 727   tiling clone,   727/727
(100 %)
1 diff
(99.9 %id)
BX380774 Placenta Cot 25-normalized .m 806 to 1577 773 to 1   tiling clone,   773/773
(100 %)
7 diff
(99.1 %id)
FN063007 breast carcinoma .n -8 to 81 1 to 90       90/90
(100 %)
6 diff
(93.4 %id)
FN063688 breast carcinoma .n 1 to 81 9 to 89       89/89
(100 %)
2 diff
(97.8 %id)
BP309614 brain .n 1 to 575 8 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA525962 brain .n 1 to 552 5 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA822421 pericardium .n 1 to 566 5 to 570   tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
DA608690   .n 6 to 542 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
BP365451 lung .n 6 to 588 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
CD579250 brain .n 8 to 757 1 to 749       749/877
(85 %)
30 diff
(96.6 %id)
CD684150 normal nasopharynx .n 13 to 163 21 to 171       151/171
(88 %)
6 diff
(96.5 %id)
TI_149294957   .n 389 to 1168 852 to 85 K2E A20L A21L AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 768/924
(83 %)
19 diff
(98.0 %id)
BM985183 lung .n 521 to 1168 666 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 648/648
(100 %)
2 diff
(99.7 %id)
BQ021782 lung, Metastatic Chondrosarcoma .n 529 to 1168 659 to 20   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 640/640
(100 %)
2 diff
(99.7 %id)
CB156972 Liver .o 1 to 478 1 to 478 A2T C3R L4* tiling clone,   478/478
(100 %)
6 diff
(98.8 %id)
BF437111 Prostate .p 1 to 481 481 to 1 exact tiling clone,   481/481
(100 %)
0 diff
(100 %id)
AI688685 colon .q 1 to 408 411 to 4 exact tiling clone,   408/411
(99 %)
0 diff
(100 %id)
AI688696 colon .q 40 to 408 372 to 4   tiling clone,   369/372
(99 %)
0 diff
(100 %id)
AA913232 pooled .r -80 to 427 511 to 1       511/511
(100 %)
60 diff
(88.3 %id)
AA927959 pooled .r -40 to 428 463 to 1       463/463
(100 %)
32 diff
(93.1 %id)
AW237520 Kidney .r 1 to 433 433 to 1 exact tiling clone,   433/433
(100 %)
3 diff
(99.4 %id)
AA507064 breast .r 20 to 427 406 to 1       406/406
(100 %)
2 diff
(99.6 %id)
AA640030 lung, lung tumor .r 21 to 426 405 to 1       405/405
(100 %)
1 diff
(99.8 %id)
AA303554 aorta .r 36 to 314 1 to 279       279/279
(100 %)
1 diff
(99.7 %id)
AW958028   .r 37 to 423 1 to 387   tiling clone, AAA   387/387
(100 %)
0 diff
(100 %id)
AA626336   .r 66 to 428 365 to 3       363/365
(99 %)
0 diff
(100 %id)
AI650289 Kidney .r 72 to 424 355 to 3       353/355
(99 %)
0 diff
(100 %id)
BG392551 embryonal carcinoma, cell line, testis .r 80 to 426 1 to 347   AAA   347/347
(100 %)
2 diff
(99.5 %id)
BG994585 head_neck .r 187 to 338 152 to 2       151/152
(99 %)
0 diff
(100 %id)
DR978004 brain .r 210 to 433 1 to 224   AAA Submitted on the opposite strand 224/224
(100 %)
3 diff
(98.7 %id)
D19889   .r 321 to 428 1 to 108     Submitted on the opposite strand 108/110
(98 %)
5 diff
(95.5 %id)
AI807414 pooled .s-u 1 to 495 495 to 1 P23X tiling clone,   495/495
(100 %)
4 diff
(99.2 %id)
AY545550   .s-u 207 to 628 10 to 431   tiling clone,   422/431
(97 %)
6 diff
(98.7 %id)
CV414004 leiomios .s-u 315 to 811 11 to 506       496/506
(98 %)
6 diff
(98.9 %id)
BE071884 breast .s-u 317 to 811 1 to 496   tiling clone,   496/496
(100 %)
22 diff
(95.6 %id)
AI831682 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .t 1 to 554 555 to 3 E4K E6D Q7S Q10R D11T ... tiling clone,   553/555
(99 %)
6 diff
(99.0 %id)
NM_001184892.1   .u 1 to 1875 1 to 1875 exact RefSeq, AAA   1875/1875
(100 %)
0 diff
(100 %id)
DA956303 Spleen .u 59 to 638 2 to 581   tiling clone, capped   580/580
(100 %)
0 diff
(100 %id)
DA383090 thalamus .u 60 to 631 2 to 573   capped   572/572
(100 %)
3 diff
(99.5 %id)
DA152139 amygdala .u 61 to 627 2 to 570   capped   569/569
(100 %)
4 diff
(99.3 %id)
DA483592 brain .u 62 to 604 2 to 544   capped   543/543
(100 %)
2 diff
(99.7 %id)
DA636171 Kidney .u 62 to 653 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DA388903 thalamus .u 68 to 659 2 to 593   capped   592/592
(100 %)
2 diff
(99.7 %id)
DA424915 colon .u 68 to 628 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB011689 esophageal, tumor tissue .u 68 to 633 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
AF218022   .u 74 to 1875 1 to 1802 exact tiling clone, AAA   1802/1802
(100 %)
0 diff
(100 %id)
CN386140 embryonic stem cells, cell lines H1, H7, andH9 .u 152 to 391 1 to 240       240/240
(100 %)
0 diff
(100 %id)
CN386139 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .u 161 to 647 1 to 486       486/486
(100 %)
1 diff
(99.8 %id)
AA478526   .u 328 to 778 27 to 478       452/478
(94 %)
6 diff
(98.8 %id)
CN386141 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .u 714 to 1133 432 to 13     Submitted on the opposite strand 420/432
(97 %)
0 diff
(100 %id)
CR743958 pooled germ cell tumors .u 853 to 1559 1 to 707       707/707
(100 %)
0 diff
(100 %id)
TI_149302887   .u 1001 to 1875 933 to 73   AAA   861/973
(88 %)
29 diff
(97.1 %id)
TI_149311479   .u 1024 to 1875 933 to 88   AAA   846/951
(88 %)
14 diff
(98.6 %id)
BE618655 eye, retinoblastoma .u 1062 to 1861 820 to 5       816/1079
(75 %)
0 diff
(100 %id)
BM977376 lung, Primary Lung Cystic Fibrosis EpithelialCells .u 1097 to 1875 798 to 19   AAA   780/780
(100 %)
2 diff
(99.8 %id)
BG285944 bladder, transitional cell papilloma, cell line .u 1154 to 1882 1 to 725       725/731
(99 %)
14 diff
(98.1 %id)
AI703369 carcinoid, lung .u 1158 to 1875 731 to 14   AAA   718/718
(100 %)
18 diff
(97.5 %id)
BQ002761 Chondrosarcoma, Left Pelvis .u 1173 to 1874 713 to 19   AAA   695/737
(94 %)
13 diff
(98.3 %id)
CB242198 Human Lung Epithelial cells, lung .u 1184 to 1875 710 to 19   AAA   692/692
(100 %)
0 diff
(100 %id)
AW188342 pooled .u 1197 to 1875 677 to 1       677/677
(100 %)
18 diff
(97.4 %id)
BM720396 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .u 1198 to 1563 1 to 366   fully sequenced,   366/366
(100 %)
0 diff
(100 %id)
BG055285 carcinoid, lung .u 1239 to 1875 654 to 18   AAA   637/637
(100 %)
12 diff
(98.2 %id)
BM981003 lung, Primary Lung Cystic Fibrosis EpithelialCells .u 1249 to 1875 639 to 19   AAA   621/621
(100 %)
3 diff
(99.6 %id)
AI241604 liver and spleen .u 1351 to 1876 530 to 6       525/537
(97 %)
0 diff
(100 %id)
BM717933 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .u 1359 to 1725 1 to 367       367/367
(100 %)
2 diff
(99.5 %id)
AA928588 pooled germ cell tumors .u 1362 to 1876 515 to 3       513/516
(99 %)
0 diff
(100 %id)
DB552610 hippocampus .u 1398 to 1873 1 to 476     Submitted on the opposite strand 476/478
(99 %)
2 diff
(99.6 %id)
DB538772 hippocampus .u 1442 to 1873 1 to 432     Submitted on the opposite strand 432/434
(99 %)
2 diff
(99.6 %id)
BM678732 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .u 1533 to 1875 361 to 19   fully sequenced, AAA   343/343
(100 %)
2 diff
(99.5 %id)
DA560643 heart .va 1 to 554 6 to 560   tiling clone, capped   559/559
(100 %)
5 diff
(99.2 %id)
BQ939808 epidermoid carcinoma, cell line, lung .va 539 to 1397 1 to 865   tiling clone,   865/867
(99 %)
14 diff
(98.4 %id)
DA619643   .vb 1 to 596 2 to 597 exact tiling clone, capped   596/596
(100 %)
1 diff
(99.9 %id)
DB039130 testis .vb 28 to 588 2 to 562   tiling clone, capped   561/561
(100 %)
0 diff
(100 %id)
AL519632 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized Gene FLAD1, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
AL519633 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized Gene FLAD1, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
DC393249 breast, tumor tissue Gene FLAD1, variant not shown         Suspected internal deletion, this clone was ignored    
AW998402 breast_normal Gene FLAD1, variant not shown         Suspected internal deletion, this clone was ignored    
AW959639   Gene FLAD1, variant not shown         Suspected internal deletion, this clone was ignored    
AA422083 ovarian tumor, ovary Gene FLAD1, variant not shown       AAA This clone was ignored    
AA422172 ovarian tumor, ovary Gene FLAD1, variant not shown         This clone was ignored    
AA422175 ovarian tumor, ovary Gene FLAD1, variant not shown       AAA This clone was ignored    
AA480112 ovarian tumor, ovary Gene FLAD1, variant not shown       fully sequenced, AAA This clone was ignored    
AA481931 ovarian tumor, ovary Gene FLAD1, variant not shown       fully sequenced, This clone was ignored    
AA628718   Gene FLAD1, variant not shown       AAA This clone was ignored    
AA582898 colon, colon tumor RER+ Gene FLAD1, variant not shown         Suspected internal deletion, this clone was ignored    
BU175895 eye, retinoblastoma Gene FLAD1, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s-u, .t, .u, .va, .vb Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI